{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:10:36Z","timestamp":1789593036381,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2025-475"],"award-info":[{"award-number":["075-15-2025-475"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM109091"],"award-info":[{"award-number":["P20GM109091"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM148351"],"award-info":[{"award-number":["R35GM148351"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.103004","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:47:57Z","timestamp":1787150877000},"page":"103004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CDK8\/19 inhibition prevents adaptive resistance to CDK4\/6 inhibitors in vitro and in vivo"],"prefix":"10.1016","volume":"7","author":[{"given":"Zachary T.","family":"Mack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Yastrebova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-uk","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvina","family":"Khamidullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Sharko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saint-Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hilimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Schools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Digsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Eckstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenael","family":"Madiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitali","family":"Sikirzhitski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoshuai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhyudai","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Tatarskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-1327","authenticated-orcid":false,"given":"Igor B.","family":"Roninson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia V.","family":"Broude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103004_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2020.08.020","article-title":"Integrating old and new paradigms for G1\/S control","volume":"80","author":"Rubin","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.103004_bib2","article-title":"CDK4\/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103004_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41388-025-03378-0","article-title":"Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment","volume":"44","author":"Guo","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103004_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","article-title":"Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer","volume":"24","author":"Luo","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.103004_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ccell.2025.02.006","article-title":"CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety","volume":"43","author":"Palmer","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103004_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103004_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"Shaffer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103004_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2020.12.002","article-title":"An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence","volume":"39","author":"Dhimolea","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103004_bib9","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/0008-5472.CAN-15-0728","article-title":"Early Adaptation and Acquired Resistance to CDK4\/6 Inhibition in Estrogen Receptor-Positive Breast Cancer","volume":"76","author":"Herrera-Abreu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/onc.2016.379","article-title":"Acquired CDK6 amplification promotes breast cancer resistance to CDK4\/6 inhibitors and loss of ER signaling and dependence","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103004_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/1078-0432.CCR-24-0036","article-title":"Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C","volume":"31","author":"O\u2019Hara","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ccell.2018.11.006","article-title":"Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4\/6 Inhibitors via the Hippo Pathway","volume":"34","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103004_bib13","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.celrep.2019.02.023","article-title":"MicroRNA-Mediated Suppression of the TGF-\u03b2 Pathway Confers Transmissible and Reversible CDK4\/6 Inhibitor Resistance","volume":"26","author":"Cornell","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103004_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41698-022-00311-6","article-title":"Co-targeting CDK2 and CDK4\/6 overcomes resistance to aromatase and CDK4\/6 inhibitors in ER+ breast cancer","volume":"6","author":"Al-Qasem","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2026.103004_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-018-0092-4","article-title":"Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer","volume":"4","author":"Guarducci","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.xcrm.2026.103004_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13058-020-01320-8","article-title":"Targeting activated PI3K\/mTOR signaling overcomes acquired resistance to CDK4\/6-based therapies in preclinical models of hormone receptor-positive breast cancer","volume":"22","author":"O\u2019Brien","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.18632\/oncotarget.28177","article-title":"GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells","volume":"13","author":"Booth","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113198","article-title":"Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4\/6 inhibitors in breast cancer","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103004_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188839","article-title":"Dual targeting of CDK4\/6 and CDK7 augments tumor response and antitumor immunity in breast cancer models","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103004_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1158\/1078-0432.CCR-23-2975","article-title":"Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor\u2013positive Breast Cancer","volume":"30","author":"Guarducci","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/0008-5472.CAN-23-0650","article-title":"Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers","volume":"84","author":"Soosainathan","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103004_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.tibs.2022.01.002","article-title":"The Mediator kinase module: an interface between cell signaling and transcription","volume":"47","author":"Luyties","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.xcrm.2026.103004_bib24","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1093\/nar\/gkad538","article-title":"CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins","volume":"51","author":"Chen","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib25","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.1710467114","article-title":"CDK8\/19 Mediator kinases potentiate induction of transcription by NF\u03baB","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103004_bib26","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.18632\/oncotarget.14894","article-title":"Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer","volume":"8","author":"McDermott","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103004_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nsmb.1752","article-title":"CDK8 is a positive regulator of transcriptional elongation within the serum response network","volume":"17","author":"Donner","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.103004_bib28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","article-title":"HIF1A employs CDK8-Mediator to stimulate RNAPII elongation","volume":"153","author":"Galbraith","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103004_bib29","doi-asserted-by":"crossref","first-page":"13799","DOI":"10.1073\/pnas.1206906109","article-title":"Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities","volume":"109","author":"Porter","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103004_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/cells10010144","article-title":"The Inhibition of CDK8\/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs","volume":"10","author":"Sharko","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103004_bib31","article-title":"Antagonizing CDK8 Sensitizes Colorectal Cancer to Radiation Through Potentiating the Transcription of e2f1 Target Gene apaf1","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.103004_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/0008-5472.CAN-21-4309","article-title":"Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors","volume":"83","author":"Malone","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201073119","article-title":"Inhibition of CDK8\/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo","volume":"119","author":"Ding","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2026.103004_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414501121","article-title":"Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors","volume":"121","author":"Ding","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2026.103004_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41698-024-00615-9","article-title":"Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK\/MAPK-targeted therapy in KRAS-mutant cancers","volume":"8","author":"Nussbaum","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2026.103004_bib36","article-title":"CDK19 and CDK8 Mediator Kinases Drive Androgen-Independent in Vivo Growth of Castration-Resistant Prostate Cancer","author":"Li","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.103004_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15916","article-title":"CDK4\/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers","volume":"8","author":"Vijayaraghavan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103004_bib38","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1021\/acs.jmedchem.1c01951","article-title":"A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8\/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.xcrm.2026.103004_bib39","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-19-0789","article-title":"Selective and Potent CDK8\/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance","volume":"19","author":"Hofmann","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2026.103004_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acsmedchemlett.9b00480","article-title":"Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity","volume":"11","author":"Grandjean","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.xcrm.2026.103004_bib41","first-page":"3147","article-title":"The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research","volume":"35","author":"Com\u015fa","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.20892\/j.issn.2095-3941.2020.0028","article-title":"Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines","volume":"17","author":"Vargas-Rond\u00f3n","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.xcrm.2026.103004_bib43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/genetics\/28.6.491","article-title":"Mutations of Bacteria from Virus Sensitivity to Virus Resistance","volume":"28","author":"Luria","year":"1943","journal-title":"Genetics"},{"key":"10.1016\/j.xcrm.2026.103004_bib44","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-20-1265","article-title":"Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer","volume":"12","author":"Chang","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103004_bib45","article-title":"Probing transient memory of cellular states using single-cell lineages","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2026.103004_bib46","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1038\/s41388-018-0316-y","article-title":"Mediator kinase CDK8\/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer","volume":"37","author":"Serrao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103004_bib47","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1158\/0008-5472.CAN-18-1583","article-title":"CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases","volume":"78","author":"Liang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-556-9_1","article-title":"Cell Senescence Culturing Methods","volume":"1048","author":"Chen","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.103004_bib52","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13105-023-00972-2","article-title":"Rab11-FIP4 interacts with ARF5 to promote cancer stemness in hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.xcrm.2026.103004_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213146119","article-title":"Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors","volume":"119","author":"Novototskaya-Vlasova","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2026.103004_bib50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1158\/0008-5472.CAN-20-0696","article-title":"Single-cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells","volume":"81","author":"Chen","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-018-0243-0","article-title":"SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior","volume":"16","author":"Brown","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.xcrm.2026.103004_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41419-021-03849-8","article-title":"Oxytocin receptor induces mammary tumorigenesis through prolactin\/p-STAT5 pathway","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.103004_bib54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12964-024-01793-6","article-title":"A SRC-slug-TGF\u03b22 signaling axis drives poor outcomes in triple-negative breast cancers","volume":"22","author":"Angel","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.xcrm.2026.103004_bib55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.18632\/oncotarget.28514","article-title":"UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology","volume":"14","author":"Price","year":"2023","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103004_bib56","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","article-title":"Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment","volume":"73","author":"Reuveni","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib57","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12032-013-0805-3","article-title":"Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer","volume":"31","author":"Singh","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.xcrm.2026.103004_bib58","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400808RR","article-title":"Research progress on interferon and cellular senescence","volume":"38","author":"Wang","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.xcrm.2026.103004_bib59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103004_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/gtc.12475","article-title":"Mediator cyclin-dependent kinases upregulate transcription of inflammatory genes in cooperation with NF-\u03baB and C\/EBP\u03b2 on stimulation of Toll-like receptor 9","volume":"22","author":"Yamamoto","year":"2017","journal-title":"Genes Cells"},{"key":"10.1016\/j.xcrm.2026.103004_bib61","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yexcr.2018.05.033","article-title":"CDK8 regulates the angiogenesis of pancreatic cancer cells in part via the CDK8-\u03b2-catenin-KLF2 signal axis","volume":"369","author":"Wei","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.xcrm.2026.103004_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.103004_bib63","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.103004_bib64","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.103004_bib65","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.xcrm.2026.103004_bib66","doi-asserted-by":"crossref","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps. 1.0.13 https:\/\/doi.org\/10.32614\/CRAN.package.pheatmap (2010).","DOI":"10.32614\/CRAN.package.pheatmap"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:46:25Z","timestamp":1789591585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004210"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103004","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDK8\/19 inhibition prevents adaptive resistance to CDK4\/6 inhibitors in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103004"}}